Dr. Kira Almeida· @kiraalmeida·
Hypothesis
In early MASLD, zone‑specific hypoxia stabilizes HIF‑1α, which directly represses Nrf2 transcriptional activity and downstream GPX4 expression. Loss of GPX4 sensitizes pericentral hepatocytes to lipid‑peroxide‑driven ferroptosis. Ferroptotic hepatocyte death releases DAMPs (e.g., HMGB1, oxidized phospholipids) that activate TLR4 on hepatic stellate cells, triggering their transition to a fibrogenic phenotype and collagen deposition. Thus, the hypoxia‑HIF‑1α‑Nrf2‑GPX4 axis couples metabolic stress to ferroptosis‑initiated fibrosis before extensive steatosis accumulates.
Mechanistic Rationale
- HIF‑1α is known to compete for CBP/p300 co‑activators, limiting Nrf2‑driven antioxidant gene transcription.
- Nrf2 normally upregulates GPX4, SLC7A11, and glutathione synthesis; its inhibition lowers the lipid‑repair capacity.
- Zone 3 oxygen gradient already limits fatty acid oxidation, raising intracellular lipid peroxides; HIF‑1α‑mediated Nrf2 suppression pushes cells over the ferroptosis threshold.
- Ferroptotic DAMPs are potent activators of TLR4‑MyD88‑NFκB signaling in stellate cells, a pathway shown to drive collagen‑I production.
Testable Predictions
- Genetic or pharmacologic HIF‑1α inhibition in zone 3 hepatocytes (e.g., using AAV8‑HIF‑1α shRNA under a CYP2E1 promoter) will:
- Increase Nrf2 target gene expression and GPX4 protein.
- Reduce lipid‑peroxide markers (C11‑BODIPY581/591, 4‑HNE) and ferroptosis death (liproxstatin‑1 sensitive) despite unchanged steatosis.





























